Evidence map›Paper›PMID 42257779›Full record

ArticleEuropean journal of epidemiology2026

Dynamics of infection, vaccination and excess mortality during the COVID-19 pandemic among older individuals-a nationwide analysis.

Eva A S Koster, Marije H Sluiskes, Hein Putter, Frits R Rosendaal, Astrid van Hylckama Vlieg, Mark G J de Boer, Liesbeth C de Wreede

Abstract read
In one paragraph

Article in European journal of epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Eva A S KosterDepartment of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands. e.a.s.koster@lumc.nl.ORCID http://orcid.org/0000-0002-8446-5133
Marije H SluiskesDepartment of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.ORCID http://orcid.org/0000-0002-2063-3492
Hein PutterDepartment of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.ORCID http://orcid.org/0000-0001-5395-1422
Frits R RosendaalDepartment of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.ORCID http://orcid.org/0000-0003-2558-7496
Astrid van Hylckama VliegDepartment of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.ORCID http://orcid.org/0000-0001-7386-1168
Mark G J de BoerDepartment of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.ORCID http://orcid.org/0000-0002-5009-6499
Liesbeth C de WreedeDepartment of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.ORCID http://orcid.org/0000-0002-7667-9369

Funding

ZonMw 10430252220011
6 · The paper itself

Abstract

The Coronavirus Diseases (COVID-19) pandemic led to excess mortality in many countries, i.e., to more deaths than expected. Older individuals generally had higher absolute risks of excess death. The complex dynamics of infection, vaccination and excess mortality have not yet been captured in one comprehensive model. With nationwide and unselected data from Statistics Netherlands, we analyzed the impact of documented infection and vaccination on excess mortality during 2020 and 2021 in the Dutch population aged over 63 on 1 January 2020 (n = 3,826,770) by incorporating relative survival into a multi-state model considering COVID-19 (re)infection, vaccination and death. Background mortality was based on the observed mortality in 2015-2019 per sex, age and month of the year. All analyses were performed for the total cohort as well as stratified per sex and age category. The absolute excess mortality in 2020-2021 was 0.34% (95% confidence interval 0.32-0.37), comprising 4.41% of the observed mortality. It was higher in men (except in the youngest age group) and older individuals. Excess mortality occurred mostly during the first four weeks after a positive COVID-19 test, but also thereafter. If infection occurred after vaccination, excess mortality was still observed, but considerably less than without prior vaccination. These patterns were observed in all groups. In conclusion, these analyses demonstrate the substantial impact of COVID-19 on excess mortality during and after acute SARS-CoV-2 infection in individuals aged over 63 years. Moreover, the results show a reduction of excess mortality after vaccination for all groups in this cohort.

Indexed as

COVID-19COVID-19 VaccinesPandemicsVaccinationAgedAged, 80 and overFemaleHumansMaleMiddle AgedMortalityNetherlandsSARS-CoV-2COVID-19 VaccinesCOVID-19 pandemicExcess mortalityMulti-state modellingRelative survivalVaccination

Identifiers

PMID42257779
PMCPMC13572326

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.